May J R, Davies J
Br Med J. 1972 Aug 12;3(5823):376-7. doi: 10.1136/bmj.3.5823.376.
Out of 210 isolates of Haemophilus influenzae obtained from the sputum of 63 patients with chronic respiratory infections 109 (52%) were resistant to trimethoprim-sulphamethoxazole by the disc test. The minimal inhibitory concentrations of trimethoprim for 17 out of 18 strains recorded as resistant were 10 mug/ml or higher. Resistant strains were isolated from time to time from 32 (82%) out of 39 patients known to have been treated with trimethoprim-sulphamethoxazole, compared with only 1 (12.5%) out of 8 patients known not to have been treated with this drug combination. Resistant strains were isolated most frequently from patients who had received long-term treatment. Since sulphamethoxazole penetrates from the blood into the bronchial secretions less readily than does trimethoprim it seems likely that the ratio of the two drugs in the bronchial tree is far from ideal. This may be an important factor in the use of these drugs for chest infections.
从63例慢性呼吸道感染患者痰液中分离出210株流感嗜血杆菌,其中109株(52%)通过纸片扩散法检测对甲氧苄啶-磺胺甲恶唑耐药。记录为耐药的18株菌株中,有17株对甲氧苄啶的最低抑菌浓度为10μg/ml或更高。已知接受过甲氧苄啶-磺胺甲恶唑治疗的39例患者中,有32例(82%)不时分离出耐药菌株,相比之下,已知未接受过该药物组合治疗的8例患者中只有1例(12.5%)分离出耐药菌株。耐药菌株最常从接受长期治疗的患者中分离出来。由于磺胺甲恶唑从血液进入支气管分泌物的速度比甲氧苄啶慢,因此支气管树中两种药物的比例似乎远不理想。这可能是这些药物用于胸部感染时的一个重要因素。